T-Cell Lymphomas, Version 2.2022

Steven M. Horwitz; Stephen Ansell; Weiyun Z. Ai; Jeffrey Barnes; Stefan K. Barta; Jonathan Brammer; Mark W. Clemens; Ahmet Dogan; Francine Foss; Paola Ghione; Aaron M. Goodman; Joan Guitart; Ahmad Halwani; Bradley M. Haverkos; Richard T. Hoppe; Eric Jacobsen; Deepa Jagadeesh; Allison Jones; Avyakta Kallam; Youn H. Kim; Kiran Kumar; Neha Mehta-Shah; Elise A. Olsen; Saurabh A. Rajguru; Sima Rozati; Jonathan Said; Aaron Shaver; Lauren Shea; Michi M. Shinohara; Lubomir Sokol; Carlos Torres-Cabala; Ryan Wilcox; Peggy Wu; Jasmine Zain; Mary Dwyer; Hema Sundar

doi:10.6004/JNCCN.2022.0015

T-Cell Lymphomas, Version 2.2022

Steven M. Horwitz
, Stephen Ansell
, Weiyun Z. Ai
, Jeffrey Barnes
, Stefan K. Barta
, Jonathan Brammer
, Mark W. Clemens
, Ahmet Dogan
, Francine Foss
, Paola Ghione
, Aaron M. Goodman
, Joan Guitart
, Ahmad Halwani
, Bradley M. Haverkos
, Richard T. Hoppe
, Eric Jacobsen
, Deepa Jagadeesh
, Allison Jones
, Avyakta Kallam
, Youn H. Kim

Kiran Kumar, Neha Mehta-Shah, Elise A. Olsen, Saurabh A. Rajguru, Sima Rozati, Jonathan Said, Aaron Shaver, Lauren Shea, Michi M. Shinohara, Lubomir Sokol, Carlos Torres-Cabala, Ryan Wilcox, Peggy Wu, Jasmine Zain, Mary Dwyer, Hema Sundar

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase–positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase–negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas.

Original language	English (US)
Pages (from-to)	285-308
Number of pages	24
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	20
Issue number	3
DOIs	https://doi.org/10.6004/JNCCN.2022.0015
State	Published - Mar 2022

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/JNCCN.2022.0015

Cite this

Horwitz, S. M., Ansell, S., Ai, W. Z., Barnes, J., Barta, S. K., Brammer, J., Clemens, M. W., Dogan, A., Foss, F., Ghione, P., Goodman, A. M., Guitart, J., Halwani, A., Haverkos, B. M., Hoppe, R. T., Jacobsen, E., Jagadeesh, D., Jones, A., Kallam, A., ... Sundar, H. (2022). T-Cell Lymphomas, Version 2.2022. JNCCN Journal of the National Comprehensive Cancer Network, 20(3), 285-308. https://doi.org/10.6004/JNCCN.2022.0015

Horwitz, SM, Ansell, S, Ai, WZ, Barnes, J, Barta, SK, Brammer, J, Clemens, MW, Dogan, A, Foss, F, Ghione, P, Goodman, AM, Guitart, J, Halwani, A, Haverkos, BM, Hoppe, RT, Jacobsen, E, Jagadeesh, D, Jones, A, Kallam, A, Kim, YH, Kumar, K, Mehta-Shah, N, Olsen, EA, Rajguru, SA, Rozati, S, Said, J, Shaver, A, Shea, L, Shinohara, MM, Sokol, L, Torres-Cabala, C, Wilcox, R, Wu, P, Zain, J, Dwyer, M & Sundar, H 2022, 'T-Cell Lymphomas, Version 2.2022', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 3, pp. 285-308. https://doi.org/10.6004/JNCCN.2022.0015

@article{fe500f027b184da189b123fc7b45feba,

title = "T-Cell Lymphomas, Version 2.2022",

abstract = "Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10\% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase–positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase–negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas.",

author = "Horwitz, \{Steven M.\} and Stephen Ansell and Ai, \{Weiyun Z.\} and Jeffrey Barnes and Barta, \{Stefan K.\} and Jonathan Brammer and Clemens, \{Mark W.\} and Ahmet Dogan and Francine Foss and Paola Ghione and Goodman, \{Aaron M.\} and Joan Guitart and Ahmad Halwani and Haverkos, \{Bradley M.\} and Hoppe, \{Richard T.\} and Eric Jacobsen and Deepa Jagadeesh and Allison Jones and Avyakta Kallam and Kim, \{Youn H.\} and Kiran Kumar and Neha Mehta-Shah and Olsen, \{Elise A.\} and Rajguru, \{Saurabh A.\} and Sima Rozati and Jonathan Said and Aaron Shaver and Lauren Shea and Shinohara, \{Michi M.\} and Lubomir Sokol and Carlos Torres-Cabala and Ryan Wilcox and Peggy Wu and Jasmine Zain and Mary Dwyer and Hema Sundar",

year = "2022",

month = mar,

doi = "10.6004/JNCCN.2022.0015",

language = "English (US)",

volume = "20",

pages = "285--308",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "3",

}

TY - JOUR

T1 - T-Cell Lymphomas, Version 2.2022

AU - Horwitz, Steven M.

AU - Ansell, Stephen

AU - Ai, Weiyun Z.

AU - Barnes, Jeffrey

AU - Barta, Stefan K.

AU - Brammer, Jonathan

AU - Clemens, Mark W.

AU - Dogan, Ahmet

AU - Foss, Francine

AU - Ghione, Paola

AU - Goodman, Aaron M.

AU - Guitart, Joan

AU - Halwani, Ahmad

AU - Haverkos, Bradley M.

AU - Hoppe, Richard T.

AU - Jacobsen, Eric

AU - Jagadeesh, Deepa

AU - Jones, Allison

AU - Kallam, Avyakta

AU - Kim, Youn H.

AU - Kumar, Kiran

AU - Mehta-Shah, Neha

AU - Olsen, Elise A.

AU - Rajguru, Saurabh A.

AU - Rozati, Sima

AU - Said, Jonathan

AU - Shaver, Aaron

AU - Shea, Lauren

AU - Shinohara, Michi M.

AU - Sokol, Lubomir

AU - Torres-Cabala, Carlos

AU - Wilcox, Ryan

AU - Wu, Peggy

AU - Zain, Jasmine

AU - Dwyer, Mary

AU - Sundar, Hema

PY - 2022/3

Y1 - 2022/3

N2 - Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase–positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase–negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas.

AB - Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase–positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase–negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas.

UR - https://www.scopus.com/pages/publications/85126389086

UR - https://www.scopus.com/pages/publications/85126389086#tab=citedBy

U2 - 10.6004/JNCCN.2022.0015

DO - 10.6004/JNCCN.2022.0015

M3 - Article

C2 - 35276674

AN - SCOPUS:85126389086

SN - 1540-1405

VL - 20

SP - 285

EP - 308

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

T-Cell Lymphomas, Version 2.2022

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this